Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Meizhong Jiahe Cancer Center is a Shanghai-based specialty oncology hospital and cancer center within the Meizhong Jiahe/Concord Healthcare Group network. The facility focuses on multidisciplinary cancer diagnosis and treatment services, with a particular emphasis on precision radiotherapy, proton therapy infrastructure, medical oncology, and diagnostic imaging. Public disclosures describe it as a flagship cancer center in Shanghai developed under the Meizhong Jiahe brand and linked to Concord Medical’s broader cancer-hospital strategy in China. The center is part of a commercial healthcare delivery business rather than a drug-development biotech company, so its value proposition is clinical oncology services, advanced treatment equipment, and specialty hospital operations rather than a therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Meizhong Jiahe Cancer Center.